glutathione iv for parkinson's disease and parkinson s disease: Is this the elephant in the room? Central nervous system uptake of – The glutathione system in Parkinson's – Remarkable Intravenous Glutathione

Observed Side Effects (From Clinical Trials) In the Lancet 2021 Phase 2 trial (n=706), at the highest 4.5 mg/week dose, 88% of participants reported at least one side effect and 63% reported a GI-specific event

BPC-157 upregulates survival genes (Akt1, KRAS, Src, Foxo1), reduces inflammatory mediators (IL-6, TNF-, NOS2, NFB), scavenges reactive oxygen species through its four carboxylic groups, activates vascular bypass pathways, and maintains blood flow despite vessel occlusion

Weeks 1 to 2: initial phase During the first two weeks, most users notice subtle improvements in skin hydration and texture

Do you suffer from hyperpigmented skin

side effects: no undesirable effects are known for this product

Metformin improves wound healing in diabetic foot ulcers: a randomized controlled trial